Cytocidal effect and DNA damage of nedaplatin: A mathematical model and analysis of experimental data

Cancer Chemotherapy and Pharmacology

Volumn 47, Issue 3, 2001, Pages 229-235

  Miyagi, Y ^a,a   Kawanishi, K ^a   Yamada, S ^a   Yamamoto, J ^a   Kodama, J ^a   Hongo, A ^a   Yoshinouchi, M ^a   Kudo, T ^a  

^a Japanese Red Cross Okayama Hospital   (Japan)

Author keywords

254 S; Computer aided; Model; Nedaplatin; Simulation

Indexed keywords

ANTINEOPLASTIC AGENT; DNA; NEDAPLATIN; PLATINUM COMPLEX; CISPLATIN;

AREA UNDER THE CURVE; ARTICLE; CELL CYCLE; CELL SURVIVAL; CHEMICAL MODEL; CLONOGENIC ASSAY; COMPUTER PROGRAM; DRUG EFFECT; THEORETICAL MODEL; CROSS LINKING; DIFFUSION; DNA DAMAGE; DRUG INFUSION; DRUG TRANSPORT; IN VITRO STUDY; INTRACELLULAR TRANSPORT; MATHEMATICAL MODEL; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; AREA UNDER CURVE; CELL CYCLE; CELL SURVIVAL; COLONY-FORMING UNITS ASSAY; DNA; MODELS, CHEMICAL; MODELS, THEORETICAL; ORGANOPLATINUM COMPOUNDS; SOFTWARE;

EID: 0034743362     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800000237     Document Type: Article

References (30)

1. Cell killing action of cell cycle phase-non-specific antitumor agents is dependent on concentration-time product
2. Kinetic analysis of cell killing effect induced by cytosine arabinoside and cisplatin in relation to cell cycle phase specificity in human colon cancer and Chinese hamster cells
3. Effect of cisplatin on cell death and DNA crosslinking in rat mammary adenocarcinoma in vitro
4. Pharmacokinetic-dynamic relationship of cisplatin in vitro: Simulation of an i.v. bolus and 3 h and 20 h infusion
5. Cytocidal effect and DNA damage of nedaplatin in vitro by simulating pharmacokinetic parameters
6. Radiation-induced DNA damage in tumors and normal tissues. IV. Influence of proliferation status and cell type on the formation of oxygen-dependent DNA damage in cultured cells
7. Synthesis of (glycolate-0,0') diammineplatinum(II) and its related complexes
8. Antitumor activity of 254-S, a platinum complex, in rodents
9. Bidentate hydroxycarboxylic acid platinum(II) complexes with antitumor activity
10. Pharmacokinetics of (glycolato-0,0')-diammine platinum(II), a new platinum derivative, in comparison with cisplatin and carboplatin
11. Fractionation of DNA from mammalian cells by alkaline elution
12. DNA damage and repair in mouse leukemia L1210 cells treated with nitrogen mustard, 1,3-bis(2-chloroethyl)-1-nitrosourea, and other nitrosoureas
13. DNA-protein crosslinking by ultraviolet radiation in normal human and xeroderma pigmentosum fibroblasts
14. Kinetics of formation and disappearance of a DNA cross-linking effect in mouse leukemia L1210 cells treated with cis- and trans-diamminedichloroplatinum(II)
15. Inhibition by 5-FU of CDDP-induced DNA interstrand crosslink removal in a HST-1 human squamous carcinoma cell line
16. Macromolecules: Structure, shape, and information
17. Characterization of a human ovarian carcinoma cell line with estrogen and progesterone receptors
18. Pharmacokinetics of cis-diammine(glycolato)platinum(254-S), a new platinum antitumor agent, following an intravenous and intraperitoneal infusion bioactive platinum concentration profile
19. Effects of combination chemoradiotherapy with daily low-dose CDDP for esophageal cancer - Results of a randomized trial
20. Pilot phase II study of 5-day continuous infusion of cisplatin in treatment of non-small cell lung cancer
21. Pharmacokinetic analysis of low-dose intraperitoneal cis-platinum administration
22. Study of serum CDDP concentrations in patients with advanced or recurrent adeno- or squamous cell carcinoma under combination chemotherapy of 5-FU (CIV) and low-dose CDDP (IV)
23. Relationship between cell-killing efficiency and number of platinum atoms binding to DNA, RNA, and protein molecules in Hela cells treated with cis-diamine(glycolato)platinum(II)
24. Ultraviolet irradiation produces cytotoxic synergy and increased DNA interstrand crosslinking with cis- and trans-diamminedichloroplatinum(II)
25. Mechanism of cis-diamminedichloroplatinum(II)-induced cytotoxity: Role of G2 arrest and DNA double-strand breaks
26. The effect of monofunctional or difunctional platinum adducts and of various other associated DNA damage on the expression of transfected DNA in mammalian cell lines sensitive or resistant to difunctional agents
27. Mechanism of cytotoxicity of anticancer platinum drugs: Evidence that cis-diamminedichloroplatinum(II) and cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) differ only in the kinetics of their interaction with DNA
28. The formation and removal of cisplatin (CDDP) induced DNA adducts in a CDDP sensitive and resistant human small cell lung carcinoma (HSCLC) cell line
29. Inhibition of cis-diamminedichloroplatinum (II)-induced DNA interstrand cross-link removal by 7-ethyl-10-hydroxy-camptothecin in HST-1 human squamous-carcinoma cells